Skip to content

Pricing Sign in

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

It was vetoed on Apr 2, 2026.

WV HB 4626 · House Bill · 2026

Stage: Vetoed
Started in: House
Sponsors: 7
Latest action: Apr 2, 2026

Where it stands

Introduced (Done)
Committee (Done)
Floor (Done)
Law (Needs attention)
Vetoed

This bill failed and is no longer moving.

Read the full text

What moved

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

Ryan BrowningLead sponsor
Adam BurkhammerCo-sponsor
Evan WorrellCo-sponsor
Mark DeanCo-sponsor
Mike HiteCo-sponsor
Rick HillenbrandCo-sponsor
Scot HeckertCo-sponsor

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Where it goes next

Once a bill is decided, the questions are about what is done with it in West Virginia.

What an agency writes to carry it outAn agency's name on a lobbying report is not a rulemaking.
Which court can stay or strike itAn opinion listed here is not yet tied to the law it reviewed.
How the place it governs is doingBecoming law is not the result. A number moving is not proof the law moved it.

Work with this bill

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine | 52